Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma

Autor: Gregory A. Jasper, Neil Basumallik, Adrian Wiestner, Gerald E. Marti, Clare Sun, Constance M. Yuan, Maryalice Stetler-Stevenson, Robert Matulonis, Jayalakshmi P. Balakrishna, Dalia A. Salem, Drake Scott
Rok vydání: 2021
Předmět:
Zdroj: Leuk Lymphoma
ISSN: 1029-2403
1042-8194
Popis: We demonstrate the prognostic utility of antigen quantitation in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and monoclonal B-cell lymphocytosis (MBL). Median antibody-bound-per-cell (ABC) of CD20, CD22, CD25, CD19, and %CD38(+) was determined in CLL (185/208), SLL (8/208) and MBL (15/208) cases by flow cytometry, then compared to Dohner-classification, immunoglobulin status (mutated, IGHV-M; unmutated, IGHV-U), CLL-IPI risk and time to first treatment (TTFT). Trisomy 12 cases showed increased %CD38-expression (p=0.0379). Higher %CD38 was observed in IGHV-U versus IGHV-M (p=0.0003). CD20ABC was increased in IGHV-U versus IGHV-M (p=0.006). Del13q cases demonstrated lower CD22ABC (p=0.0198). Cases without cytogenetic abnormality exhibited higher CD19ABC (p=0.0295) and CD22ABC (p=0.0078). Del17p cases demonstrated lower CD25ABC (p=0.0097). High and very-high CLL-IPI risk groups were associated with high CD38-expression (p=0.02) and low CD25ABC (p=0.0004). Shortened TTFT was associated with high CD38-expression (p
Databáze: OpenAIRE